Michael J.  McBreen net worth and biography

Michael McBreen Biography and Net Worth

Michael McBreen is the executive vice president and president, Codman Specialty Surgical. He is responsible for overall strategic direction and commercial operations of the company’s market leading neurosurgical portfolio and broad surgical instrumentation offering.

Mr. McBreen is a 30-year veteran of the medical device industry. He joined Integra following the acquisition of Codman Neurosurgery from Johnson & Johnson in October 2017. As president of Integra’s international division, he led the expansion of Integra’s business in all regions of the world outside of the United States, representing approximately 30 percent of the company’s overall revenues.

Prior to Integra, Mr. McBreen served as vice president, U.S. commercial and global marketing for Codman neurosurgery and neurovascular businesses. Previously, he was worldwide vice president for professional education for the Johnson & Johnson medical device and diagnostics division. Mr. McBreen also held numerous U.S. and global roles of increasing responsibilities in sales and marketing at DePuy Mitek Sports Medicine, a division of Johnson & Johnson, since joining the company in 1996. Prior to Johnson & Johnson, he held various sales and marketing roles at Zimmer Biomet.

Mr. McBreen has served as a corporate advisory board member for the American Orthopaedic Society for Sports Medicine and on the Board of Trustees for the Arthroscopy Association of North America Education Foundation. He is a board member of the ThinkFirst Foundation.

Mr. McBreen completed his bachelor’s degree in business administration at Providence College.

What is Michael J. McBreen's net worth?

The estimated net worth of Michael J. McBreen is at least $699,166.88 as of March 7th, 2023. Mr. McBreen owns 28,796 shares of Integra LifeSciences stock worth more than $699,167 as of November 13th. This net worth estimate does not reflect any other investments that Mr. McBreen may own. Additionally, Mr. McBreen receives a salary of $611,280.00 as EVP at Integra LifeSciences. Learn More about Michael J. McBreen's net worth.

How old is Michael J. McBreen?

Mr. McBreen is currently 57 years old. There are 7 older executives and no younger executives at Integra LifeSciences. The oldest executive at Integra LifeSciences is Mr. Robert T. Davis Jr., Executive VP & President of Tissue Technologies, who is 65 years old. Learn More on Michael J. McBreen's age.

What is Michael J. McBreen's salary?

As the EVP of Integra LifeSciences Holdings Co., Mr. McBreen earns $611,280.00 per year. There are 2 executives that earn more than Mr. McBreen. The highest earning executive at Integra LifeSciences is Mr. Jan De Witte, President, CEO & Director, who commands a salary of $888,670.00 per year. Learn More on Michael J. McBreen's salary.

How do I contact Michael J. McBreen?

The corporate mailing address for Mr. McBreen and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Michael J. McBreen's contact information.

Has Michael J. McBreen been buying or selling shares of Integra LifeSciences?

Michael J. McBreen has not been actively trading shares of Integra LifeSciences during the last quarter. Most recently, Michael J. Mcbreen sold 1,843 shares of the business's stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $54.29, for a transaction totalling $100,056.47. Following the completion of the sale, the executive vice president now directly owns 28,796 shares of the company's stock, valued at $1,563,334.84. Learn More on Michael J. McBreen's trading history.

Who are Integra LifeSciences' active insiders?

Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.

Are insiders buying or selling shares of Integra LifeSciences?

In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 52,641 shares worth more than $1,499,742.09. The most recent insider tranaction occured on May, 23rd when Chairman Stuart Essig bought 52,641 shares worth more than $1,499,742.09. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.

Information on this page was last updated on 5/23/2024.

Michael J. McBreen Insider Trading History at Integra LifeSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2023Sell1,843$54.29$100,056.4728,796View SEC Filing Icon  
11/5/2021Sell3,450$71.59$246,985.50View SEC Filing Icon  
See Full Table

Michael J. McBreen Buying and Selling Activity at Integra LifeSciences

This chart shows Michael J Mcbreen's buying and selling at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integra LifeSciences Company Overview

Integra LifeSciences logo
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $23.31
Low: $23.24
High: $24.84

50 Day Range

MA: $19.37
Low: $16.95
High: $26.70

2 Week Range

Now: $23.31
Low: $16.81
High: $45.42

Volume

1,324,480 shs

Average Volume

1,103,499 shs

Market Capitalization

$1.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08